SARAH DOERNBERG, MD
Osteopathic Medicine at Parnassus Ave, San Francisco, CA

License number
California A103536
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
505 Parnassus Ave ROOM M987, San Francisco, CA 94143
Phone
(415) 476-1528

Personal information

See more information about SARAH DOERNBERG at radaris.com
Name
Address
Phone
Sarah Doernberg, age 45
550 Lake St APT 304, San Francisco, CA 94118
Sarah Doernberg
104 Frederick St, San Francisco, CA 94117
(415) 865-9718

Organization information

See more information about SARAH DOERNBERG at bizstanding.com

Sarah Doernberg MD

505 Parnassus Ave, San Francisco, CA 94131

Industry:
Internist
Phone:
(415) 476-1528 (Phone)
Sarah Beth Doernberg

Professional information

Sarah Doernberg Photo 1

Dr. Sarah Doernberg, San Francisco CA - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
UCSF Infectious Disease Clinic
400 Parnassus Ave SUITE 591, San Francisco 94143
(415) 353-2626 (Phone)
Certifications:
Infectious Disease, 2011, Internal Medicine, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UCSF Infectious Disease Clinic
400 Parnassus Ave SUITE 591, San Francisco 94143
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
Education:
Medical School
Yale Univ Sch Of Med
Graduated: 2005


Sarah Beth Doernberg Photo 2

Sarah Beth Doernberg, San Francisco CA

Specialties:
Internal Medicine, Infectious Disease
Work:
UCSF Medical Center / Moffitt-Long Hospitals
400 Parnassus Ave, San Francisco, CA 94143
Education:
Yale University (2006)


Sarah Doernberg Photo 3

Sarah Doernberg, San Francisco CA

Specialties:
Internist
Address:
513 Parnassuf Ave., San Francisco, CA 94143
513 Parnassus Ave., San Francisco, CA 94143


Sarah Doernberg Photo 4

Mif Agonists And Antagonist And Therapeutic Uses Thereof

US Patent:
2010014, Jun 10, 2010
Filed:
Apr 26, 2006
Appl. No.:
11/919307
Inventors:
Richard Bucala - Cos Cob CT, US
Lin Leng - New York NY, US
Sarah Doernberg - San Francisco CA, US
International Classification:
A61K 38/22, C12Q 1/68, C07H 21/04, C40B 40/06, A61K 31/7088, A61K 39/395, G01N 33/53, A61P 7/06, A61P 31/00
US Classification:
4241721, 435 6, 536 2432, 506 16, 514 44 A, 514 8, 436501
Abstract:
The present invention relates to methods and compositions for selecting a subject for treatment with an agonist or antagonist of macrophage migration inhibitory factor (MIF), identifying a subject at risk for developing a disease associated with high or low MIF expression, predicting the severity of a disease associated with high or low MIF expression in a subject, and for predicting whether a subject is susceptible to a disease associated with high or low MIF expression. The invention also provides novel methods of diagnosing a patient for a disease associated with high or low MIF expression. Also provided are methods for treating a subject having a disease or disorder associated with high or low MIF expression.